Home
About
Overview
Sharing Data
ORCID
Help
History (11)
The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity.
Expectations of an emergency medicine clerkship director.
Personality disorder and mild traumatic brain injury.
Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.
Mechanisms of pulmonary edema clearance.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Dolan, Mary Eileen
One or more keywords matched the following properties of
Dolan, Mary Eileen
Property
Value
keywords
Pharmacogenomics
One or more keywords matched the following items that are connected to
Dolan, Mary Eileen
Item Type
Name
Concept
Pharmacogenetics
Academic Article
Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 gene.
Academic Article
Characterization of multiple promoters in the human carboxylesterase 2 gene.
Academic Article
Effect of population and gender on chemotherapeutic agent-induced cytotoxicity.
Academic Article
Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.
Academic Article
The pharmacogenetics research network: from SNP discovery to clinical drug response.
Academic Article
Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity.
Academic Article
Identification of genetic variants and gene expression relationships associated with pharmacogenes in humans.
Academic Article
Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines.
Academic Article
Identification of genomic regions contributing to etoposide-induced cytotoxicity.
Academic Article
Use of cell lines in the investigation of pharmacogenetic loci.
Academic Article
Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy.
Academic Article
Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies.
Academic Article
Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy.
Academic Article
Impact of the 1000 genomes project on the next wave of pharmacogenomic discovery.
Academic Article
Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines.
Academic Article
Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci.
Academic Article
The emerging role of microRNAs in drug responses.
Academic Article
Chemotherapeutic-induced apoptosis: a phenotype for pharmacogenomics studies.
Academic Article
Clinically relevant genetic variations in drug metabolizing enzymes.
Academic Article
Functional consequences of PRPF39 on distant genes and cisplatin sensitivity.
Academic Article
Mixed effects modeling of proliferation rates in cell-based models: consequence for pharmacogenomics and cancer.
Academic Article
PACdb: a database for cell-based pharmacogenomics.
Academic Article
Pharmacogenomic discovery using cell-based models.
Academic Article
Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation.
Academic Article
Relating human genetic variation to variation in drug responses.
Academic Article
Clinical translation of cell-based pharmacogenomic discovery.
Academic Article
Copy number polymorphisms and anticancer pharmacogenomics.
Academic Article
Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis.
Academic Article
The HapMap Resource is Providing New Insights into Ourselves and its Application to Pharmacogenomics.
Academic Article
A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.
Academic Article
Creating and evaluating genetic tests predictive of drug response.
Academic Article
Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.
Academic Article
Genetics and variable drug response.
Academic Article
Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.
Academic Article
Cancer pharmacogenomics: strategies and challenges.
Academic Article
Lymphoblastoid cell lines in pharmacogenomics: how applicable are they to clinical outcomes?
Academic Article
Ancestry-related differences in gene expression: findings may enhance understanding of health disparities between populations.
Academic Article
Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy.
Academic Article
Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology Group.
Academic Article
Genetic and epigenetic variants contributing to clofarabine cytotoxicity.
Academic Article
Institutional Profile: University of Chicago Center for Personalized Therapeutics: research, education and implementation science.
Academic Article
Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses.
Academic Article
Pharmacogenomics of chemotherapeutic susceptibility and toxicity.
Academic Article
RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.
Academic Article
Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy.
Academic Article
Integration of genetic and functional genomics data to uncover chemotherapeutic induced cytotoxicity.
Academic Article
Genetically regulated expression underlies cellular sensitivity to chemotherapy in diverse populations.
Academic Article
Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy.
Search Criteria
Pharmacogenomics